Master Specialist Anesthesia (ANA5781)
for DHA Speciality

Core Concepts

Specialist anesthesia requires a profound understanding of applied pharmacology, physiology, and pathology to ensure patient safety and optimal surgical conditions. Key areas include:

• Pharmacology: Mechanism of action, pharmacokinetics, pharmacodynamics, and interactions of inhalational and intravenous anesthetics, opioids, muscle relaxants, local anesthetics, vasopressors, inotropes, and emergency drugs.
• Physiology: Comprehensive knowledge of cardiovascular, respiratory, renal, neurological, endocrine, and hepatic systems, and their alterations by disease states, surgery, and anesthetic agents.
• Airway Management: Assessment, prediction, and management of normal and difficult airways (basic, advanced, rescue techniques, algorithms).
• Monitoring: Principles and interpretation of standard ASA monitors (ECG, SpO2, NIBP, EtCO2, Temperature) and advanced monitoring (invasive BP, CVP, TEE, TOF, BIS/Entropy).
• Regional Anesthesia: Anatomy, techniques, indications, contraindications, and complications of neuraxial and peripheral nerve blocks.
• Crisis Management: Recognition and management of life-threatening anesthetic emergencies (e.g., malignant hyperthermia, anaphylaxis, local anesthetic systemic toxicity, massive hemorrhage, cardiac arrest).
• Perioperative Medicine: Pre-operative assessment, risk stratification (ASA, P-POSSUM), optimization of comorbidities, pain management (acute & chronic), post-anesthesia care, and Enhanced Recovery After Surgery (ERAS) protocols.
• Patient Safety & Quality Improvement: Human factors, error prevention, critical incident analysis, communication, and teamwork.
• Ethics & Medicolegal: Informed consent, confidentiality, professional responsibility, and medicolegal aspects of anesthesia practice.

Clinical Presentation

• Pre-operative Assessment: Identification of patient risk factors (e.g., morbid obesity, OSA, severe cardiac/pulmonary disease, history of difficult airway or adverse anesthetic events) impacting anesthetic plan and outcomes.
• Intra-operative Events:
  • Hypotension/Hypertension: Sudden changes in blood pressure, often due to drug effects, fluid shifts, surgical stimulus, or underlying pathology.
  • Bradycardia/Tachycardia/Arrhythmias: Changes in heart rate/rhythm, potentially from vagal stimulation, anesthetic agents, hypoxemia, or myocardial ischemia.
  • Hypoxemia/Hypercapnia: Decreased SpO2 or rising EtCO2, indicating ventilation/perfusion mismatch, airway obstruction, bronchospasm, or hypoventilation.
  • Bronchospasm: Wheezing, increased airway pressures, decreased EtCO2 return, often sudden onset.
  • Malignant Hyperthermia (MH): Unexplained tachycardia, hypercarbia (rising EtCO2 despite increased ventilation), muscle rigidity, rapidly rising temperature (late sign).
  • Anaphylaxis: Sudden hypotension, bronchospasm, skin changes (urticaria, angioedema), often refractory to standard treatment.
  • Local Anesthetic Systemic Toxicity (LAST): Perioral numbness, tinnitus, metallic taste, agitation, seizures, followed by cardiovascular collapse (bradycardia, hypotension, arrhythmias).
  • Awareness: Unexplained hypertension, tachycardia, lacrimation, movement, followed by patient recall post-op.
• Post-operative Complications: Nausea and vomiting (PONV), pain, respiratory depression, delirium, emergence agitation, shivering, residual neuromuscular blockade.

Diagnosis (Gold Standard)

Diagnosis in anesthesia relies heavily on real-time monitoring, clinical assessment, and rapid interpretation.

• Pre-operative: Thorough history and physical examination, relevant laboratory tests (CBC, electrolytes, renal/hepatic function), ECG, pulmonary function tests, cardiac assessment (echo, stress test) as indicated. ASA physical status classification. Difficult airway assessment (LEMON criteria, Mallampati, thyromental distance).
• Intra-operative: Continuous monitoring of ECG, SpO2, NIBP, EtCO2, Temperature. Use of invasive monitors (arterial line, CVP) for high-risk cases.
  • MH: Sustained rise in EtCO2 despite hyperventilation, rigidity, Tachycardia. Confirmed genetically (ryanodine receptor gene mutations), but clinically diagnosed by acute crisis.
  • Anaphylaxis: Clinical presentation. Elevated mast cell tryptase and histamine levels (post-event) for confirmation.
  • LAST: Clinical signs and symptoms. Serum local anesthetic levels (confirmatory, not real-time diagnostic).
  • Neuromuscular Blockade: Train-of-Four (TOF) monitoring.
• Post-operative: Clinical assessment using validated scoring systems (e.g., Aldrete score for discharge from PACU), pain scales, and symptom assessment.

Management (First Line)

Immediate, decisive action is critical in anesthetic management.

• General Principles: Maintain ABCs (Airway, Breathing, Circulation), cease offending agent, call for help, supportive therapy, specific antidotes.
• Difficult Airway: Follow a structured algorithm (e.g., DAS guidelines, ASA Difficult Airway Algorithm). Maintain oxygenation (BDA - Bag, Device, Airway adjuncts). Call for help. Supraglottic airway device. Fiberoptic intubation. Surgical airway (cricothyroidotomy) as a last resort.
• Hypotension: Increase fluid administration, decrease anesthetic depth, administer vasopressors (e.g., phenylephrine, ephedrine, norepinephrine).
• Bradycardia: Administer anticholinergics (e.g., atropine, glycopyrrolate). Address underlying cause (e.g., hypoxia, opioids).
• Bronchospasm: 100% O2, deepen anesthesia with volatile agent, administer inhaled beta-agonists (salbutamol), IV corticosteroids, IV epinephrine in severe cases.
• Malignant Hyperthermia (MH): Stop all volatile agents and succinylcholine. Hyperventilate with 100% O2. Administer IV dantrolene (2.5 mg/kg bolus, repeat until symptoms subside). Cool patient. Treat acidosis and hyperkalemia.
• Anaphylaxis: IM/IV epinephrine (dose varies by severity). Large volume IV fluids. Antihistamines, corticosteroids, bronchodilators.
• Local Anesthetic Systemic Toxicity (LAST): Stop LA injection. Call for help. Maintain airway and ventilation (100% O2). Treat seizures with benzodiazepines. Administer IV lipid emulsion (20% lipid emulsion 1.5 mL/kg bolus over 1 min, followed by 0.25 mL/kg/min infusion).
• Post-operative Nausea/Vomiting (PONV): Prophylactic antiemetics (e.g., ondansetron, dexamethasone). Treatment includes serotonin antagonists, dopamine antagonists.
• Post-operative Pain: Multimodal analgesia approach (NSAIDs, acetaminophen, regional blocks, opioids).

Exam Red Flags